都福 (DOV) 2026 年第三季財報電話會議:訂單成長 16%,財測指引收窄上調
杜福爾公司公布 2026 財年第三季有機成長加速至 7%,調整後 EPS 年增 10% 至 2.88 美元。在手訂單大增 35%,帶動全年財測收窄至頂端,預期有機成長 5%–6%,調整後 EPS 達 10.60–10.75 美元。氣候與永續技術事業群因資料中心液冷與 CO2 制冷需求強勁,引領有機成長 18%。自由現金流達 3.83 億美元。管理層指出資本配置將優先回饋股東,並看好 2027 年在手訂單與產能擴充帶來的持續動能。
杜福爾公司 (Dover Corporation, NYSE: DOV) 公布 2026 財年第三季有機成長加速、各業務訂單動能強勁且自由現金流增加。管理層收窄全年財測指引至先前預測區間的頂端,並指出在手訂單大幅成長 35%,為邁入 2027 年提供關鍵的可見度。
重點摘要
- 第三季有機營收成長加速至 7%,調整後每股盈餘 (EPS) 年增 10% 至 2.88 美元。
- 五大事業群訂單全面成長 16%,單季訂單出貨比 (book-to-bill ratio) 達 1.03。在手訂單年增 35%,其中約半數預計於 2027 年出貨。
- 氣候與永續技術事業群以 18% 的有機成長率領跑,主要由資料中心液冷熱交換器以及二氧化碳 (CO2) 制冷系統創紀錄的單季營收所支撐。
- 第三季自由現金流達 3.83 億美元,佔營收 17%。今年前三季自由現金流增加 7,200 萬美元,達 7.03 億美元。
- 杜福爾收窄全年財測指引,預計有機成長率為 5%–6%,調整後 EPS 為 10.60–10.75 美元。
- 公司在第三季庫藏股買回超過 3.3 億美元股票,今年至今累計約 4 億美元。管理層表示,短期內的資本配置仍傾向於回饋股東。
關鍵財務數據
| 指標 | 2026 年第三季 / 目前狀況 | 變動或背景說明 |
|---|---|---|
| 有機營收成長率 | 7% | 成長在本季度有所加速 |
| 調整後 EPS | 2.88 美元 | 年增 10% |
| 訂單 | 年增 16% | 五大事業群全面成長 |
| 單季訂單出貨比 | 1.03 | 訂單金額大於出貨金額 |
| 過去 12 個月訂單出貨比 | 1.08 | 過去 12 個月訂單金額成長 16%,相對應營收成長率為 8% |
| 在手訂單 | 年增 35% | 約半數排定於 2027 年出貨 |
| 第三季自由現金流 | 3.83 億美元 | 佔營收 17% |
| 今年至今累計自由現金流 | 7.03 億美元 | 佔營收 11%,且同比增加 7,200 萬美元 |
| 今年至今累計庫藏股買回 | 約 4 億美元 | 包括第三季買回的 3.3 億美元以上 |
| 已宣布之收購承諾金額 | 約 8,000 萬美元 | Cloeren 與 Leistung |
| 季末可用資本容量 | 超過 30 億美元 | 被管理層稱為「乾柴(可支配資金)」 |
業務與營運表現
杜福爾表示,其長期結構性成長市場現已佔總營收 25% 以上,高於 2024 年的 18%。這些市場包括能源轉型與發電、二氧化碳 (CO2) 系統、資料中心,以及用於能源與航太領域的超低溫零組件。
氣候與永續技術實現 18% 的有機成長。硬焊板式熱交換器在各個地理區域與終端市場的需求持續強勁,特別是用於資料中心液冷領域。杜福爾正持續投資,預計在 2027 年前將大型熱交換器的全球產能翻倍。
二氧化碳制冷系統締造單季歷史新高營收。維吉尼亞州里奇蒙 (Richmond) 工廠產出有所改善,出貨線速度較第二季提高 15%。該事業群利潤率為 18%,主因是熱交換器強勁的轉換率被 CO2 系統、特種展示櫃與冷藏門櫃同時擴產所產生的成本所抵銷。
食品零售業務今年至今吸收了約 4,000 萬美元的相關成本,包括生產投資、額外勞工費用,以及因同時營運兩間工廠所產生的重複固定成本。杜福爾已於本季完成加州西爾馬 (Sylmar) 門框生產線的整合。
潔淨能源與加油設備有機成長 12%。成長動能來自潔淨能源零組件、流體運輸以及北美零售加油設備,後者錄得近年來最強勁的單季表現。用於液化天然氣 (LNG) 與航太發射基礎設施的超低溫零組件需求維持健康。由於產能提升成本抵銷了規模效益,利潤率大致持平。
影像與識別實現 2% 的有機成長,主因是序列化軟體錄得雙位數成長,以及標記與噴碼需求穩健。在營運槓桿、軟體成長、區域產品組合與外匯換算的支撐下,營業利潤率擴增 400 個基點至 33%。
幫浦與製程解決方案有機成長 1%。人工智慧 (AI) 及能源基礎設施、一次性生技製藥以及工業幫浦的成長,抵銷了高分子聚合物加工設備出貨下滑的影響。受惠於工業幫浦與精密零組件的利潤轉化率優異,加上生技製藥產品比重提高,利潤率提升 70 個基點至 34%。
工程產品有機下滑 2%。航太與國防零組件的強勁需求,被歐洲車輛服務出貨量下滑所抵銷。受惠於有利的產品組合與成本控制,利潤率保持穩定。
杜福爾持續投資於加油設備、超低溫零組件、美國流量計、亞洲一次性生技製藥零組件、航太射頻設備、印表機與墨水生產、特種展示櫃以及大型熱交換器的新產能。許多項目預計將於 2027 年第一季末前投入營運。
公司亦於 8 月完成對 Cloeren 的收購,並預計 Leistung 的交易將於第四季完成。Cloeren 為公司增加了擠出模具、分流板以及超過 30 萬平方英呎的美國製造產能。Leistung 則將在印度提供超低溫零組件的製造產能。
管理層財測指引
杜福爾收窄其 2026 全年展望至先前預測區間的頂端:
| 全年指標 | 管理層財測指引 |
|---|---|
| 有機成長率 | 5%–6% |
| 調整後 EPS | 10.60–10.75 美元 |
| 自由現金流 | 佔營收 14%–16% |
| 資本支出 | 2 億–2.2 億美元 |
管理層預計自由現金流將在第四季進一步增加,第四季歷來是杜福爾現金生成能力最強的季度。
展望 2027 年,管理層提到了在手訂單、重組省下的成本、收購帶來的貢獻、流動股數減少,以及預期食品零售轉型成本下降等支撐因素。杜福爾未提供正式的 2027 年財務指引,但表示氣候與永續技術事業群的利潤率應會顯著改善,且預計自第一季開始實現同比利潤率提升。
風險與關注焦點
- 產能限制正拉長熱交換器、超低溫產品及部分加油設備市場的交貨期。新產能需要前期資本投入,且在產能利用率提升之前可能會稀釋利潤率。
- 第四季出貨時程部分取決於客戶在 12 月的提貨指示,因為客戶可能在年底進行營運資金管理。
- 食品零售擴產成本預計將在年底前繼續上升,之後生產力與固定成本分攤才會改善。在出貨量維持支撐的前提下,管理層預計轉型工作將於 2027 年第一季末大致完成。
- 為因應大宗商品及其他成本投入的曝險,杜福爾已在 2027 年到來前加速推動特定產品的漲價措施。SWEP 對銅價格的曝險已納入供應商合約定價機制中。
- 管理層承認,隨著競爭對手也擴充產能,資料中心需求的持續時間存在不確定性;不過杜福爾表示,目前在手的訂單足以支撐其投資計劃。
- 在傳統短週期業務中,可見度仍較受限,因為這些業務通常接單到出貨的時間間隔較短。
法人說明會問答亮點
在手訂單與 2027 年可見度:管理層表示,在手訂單高於正常水準,是因為產能受限市場的客戶提早預訂產能。在手訂單主要集中在 CO2 系統與 SWEP 熱交換器,而非傳統長週期業務。若聚合物加工與製罐設備從目前的低點復甦,杜福爾亦看好潛在的上行空間。
氣候與永續技術利潤率:管理層拒絕量化 2027 年的利潤率增幅,但稱其將相當顯著。預期的改善動力來自消除重複的廠房成本、穩定生產線、減少過剩人力,以及透過更高產量來分攤固定成本。
資料中心冷卻產能:杜福爾正在擴充 SWEP 主力資料中心產品線的產能,並預期未來的產品組合將從中央冷卻系統轉向冷卻液分配裝置 (CDU)。管理層表示,由於生產高度自動化且技術要求高,產能決策必須提前大約 18 個月做出。
資本配置:杜福爾對補充型收購仍持開放態度,但將堅持其報酬標準。管理層表示,有機項目帶來的營收成長可能與收購相當,並重申短期內偏好將資本回饋給股東。
零售加油設備週期:管理層表示,地下儲油槽設備的供應限制延長了資本支出週期的持續時間。杜福爾目前認為該週期可能至少持續四年,而先前預估為三年。
利率影響:當被問及高利率是否影響到進行資本規劃的業務時,管理層回答稱尚未看到影響。
財報電話會議完整逐字稿
完整財報電話會議逐字稿
管理層陳述
Operator
Good morning, and welcome to Dover's Third Quarter 2026 Earnings Conference Call. Speaking today are Richard J. Tobin, President and Executive -- Chief Executive Officer; Chris Woenker, Senior Vice President and Chief Financial Officer; and Jack Dickens, Vice President, Investor Relations. [Operator Instructions] As a reminder, ladies and gentlemen, this conference call is being recorded, and your participation implies consent to our recording of this call. If you do not agree with this term, please disconnect at this time. Thank you.
I would now like to turn our call over to Mr. Jack Dickens. Please go ahead, sir.
Jack Dickens
Thank you, Leslie. Good morning, everyone, and thank you for joining our call. An audio version of this call will be available on our website through November 12, and a replay link of the webcast will be archived for 90 days.
Our comments today will include forward-looking statements based on current expectations. Actual results and events could differ from those statements due to a number of risks and uncertainties, which are discussed in our SEC filings. We assume no obligation to update our forward-looking statements.
With that, I will turn the call over to Rich.
Richard Tobin
Thanks. Jack. Good morning, everyone. Let's get started on Slide 3. Overall, it was a solid quarter. Organic growth accelerated to 7%, led by our secular growth markets and supported by durable demand across the majority of the portfolio. Bookings were the highlight in the quarter. Orders were up 16% year-over-year, with growth in all 5 segments. Book-to-bill was 1.03 for the quarter. Our backlog is up 35% versus this time last year, which supports our confidence in the forecast and provides very good momentum heading into 2027.
Adjusted EPS was $2.88 per share, up 10% in the quarter. We remain active on the capital -- on capital deployment, announcing 2 bolt-on acquisitions that add complementary capabilities, low-cost manufacturing and geographic breadth to our businesses. We also repurchased over $330 million of our shares in the quarter. We are narrowing our full year guidance towards the upper end of the range, with organic growth of 5% to 6% and adjusted EPS and from $10.60 to $10.75 per share, representing double-digit growth consistent with our long-term algorithm.
Let's go to Slide 5. Our secular growth markets now represent over 25% of our total revenue, up from 18% in 2024. Across the top of the slide, we show our expected growth rates in each of these markets this year. In total, these markets are a material driver of our overall revenue growth in 2026, and we expect that trend to continue in 2027. We have purposely built these platforms through R&D spending and new product development in our legacy businesses as well as through targeted M&A.
Our business model is unique. It allows us to pursue a variety of high-growth business opportunities across a range of secular themes, with several of our businesses participating in more than one. We have been able to deliver this growth by proactively adding capacity in advance to the market, which has allowed us to capture leadership positions. This has been particularly important in energy transition and power generation, CO2 systems, data centers and cryogenic components serving the energy and space markets. We have continued to invest in additional capacity in 2026 behind this demand strength, some of which we will detail in a subsequent slide.
These organic and inorganic investments have delivered high returns on invested capital despite the proactive upfront investments as the result -- as a result of high growth rates and margin profiles of these sectors. These businesses are technically demanding mission-critical applications where Dover tends to win. The vast majority of our acquisition capital over the past 5 years has been deployed in these markets, and they remain our top priorities from both an organic and inorganic investment.
Going to Slide 6. This slide underscores the breadth and duration of our order book. Trailing 12-month bookings were up 16%, well ahead of revenue growth at 8, and trailing book-to-bill has climbed to 1.08. Every segment has grown bookings faster than revenue over the past 12 months. That sustained order momentum has underpinned the top line acceleration we are seeing in 2026, and it gives us confidence in our outlook going forward. Importantly, our backlog is 35% higher than it was at this point last year and is up sequentially from Q2, with roughly half scheduled to ship in 2027. That gives us a solid foundation heading into next year with revenue visibility well ahead of where we would expect to be at this point in the planning cycle.
Moving to Slide 7. Engineered Products was down 2% organically. Demand for aerospace and defense components remained strong, was more than offset by lower volumes in European vehicle services. Margin was stable on favorable mix and cost controls.
Clean Energy & Fueling grew 12% organically, with solid shipments in new orders in clean energy components, fluid transport and North American retail fueling, which posted its strongest quarter in years. Demand for our cryogenic components in LNG and space launch infrastructure remains healthy, with several recent high-profile project wins. Margin was roughly flat as volume leverage was offset by production ramp in cryogenic product lines where demand is running ahead of capacity. We're actively expanding that capacity with additional output coming online in the first quarter of 2027.
Imaging & ID grew 2% organically, led by double-digit growth in serialization software and solid performance in core marking and coding. Consumables and equipment margins expanded 400 basis points to 33%, driven by volume leverage on largely fixed cost base and software growth in consumables, favorable geographic mix and foreign currency translation.
Pumps & Process Solutions grew 1% organically, with growth in AI and energy infrastructure, single-use biopharma and industrial pumps that was partially offset by lower volumes in polymer processing equipment where quoting activity is high. Margin expanded 70 basis points to 34% and solid conversion in industrial pumps and precision components and a higher mix of biopharma revenue.
Climate & Sustainability Technologies accelerated to 18% organic growth in the quarter. Shipments and order rates in brazed plate heat exchanges remain robust across all geographies and major end markets, with notable strength in liquid cooling for data centers which is initially concentrated in the U.S., but we are now seeing meaningful acceleration in Europe and Asia. Lead times remain extended and we are actively investing to double our global capacity for large heat exchanges through 2027.
CO2 refrigeration systems posted quarterly revenue -- posted record quarterly revenue with September reaching its highest output of the year in refrigerated door cases. The investments that we have added in Richmond, Virginia facility are ramping up. Line rates exiting third quarter were 15% higher than the second quarter. We expect another sequential increase in line rates and output in the fourth quarter. We also completed the consolidation of the door frame production in Sylmar, California at the end of the quarter.
Segment margin was 18%. Margins in heat exchanges were robust as volumes outrun the significant investments in capacity build. With direct labor, less than 10% of its cost base, this business converts incremental volume exceptionally well. Those gains in heat exchangers were offset by cost of ramping production simultaneously across CO2 systems, specialty cases and refrigerator door cases ahead of higher demand and shipment rates in 2027, which is reflected in our backlog. Heat exchangers should continue to benefit from [ via ] leverage in 2027, with a good portion of Q1 revenue already in backlog.
In food retail, we have absorbed roughly $40 million of costs year-to-date from investments and extra labor costs associated with the production ramp along with duplicate fixed costs of running 2 facilities for the throughput of 1. As line rates continue to ramp and as the roll-off of fixed cost accelerates through the balance of the year, margins in Climate & Sustainability Technologies are poised to improve meaningfully in 2027.
I'll pass it over to Chris.
Christopher Woenker
Thanks, Rich, and good morning, everyone. Let's go to our cash flow statement on Slide 8. Year-to-date, free cash flow was $703 million or 11% of revenue, up $72 million over the prior year, driven primarily by increased operating cash conversion which more than offset working capital investments to support accelerating top line growth. Third quarter free cash flow was $383 million or 17% of revenue. We've taken up our full year CapEx guide for the year to reflect the organic investments we're making behind demand strength. Free cash flow accelerated in the third quarter, consistent with historical trends, and we expect a further increase in the fourth quarter, which is historically our highest cash-generating quarter. Our full year free cash flow guidance remains on track at 14% to 16% of revenue.
With that, let me turn it back to Rich.
Richard Tobin
Okay. I'm on Slide 9. Organic investment remains our highest return use of capital. On the left are our most meaningful projects. In support of our organic revenue trajectory, we have greenfield expansions underway in below ground retail fueling, cryogenic components, flow meters in the U.S. and single-use biopharma components in Asia, along with capacity investments in radio frequency equipment for space, printer and ink production and specialty cases in CO2 systems and large heat exchanges. Many of these projects will be online by the end of the first quarter of 2027.
On the productivity side, we are optimizing our vehicle services footprint, extracting synergies from our polymer processing acquisition and have now completed the footprint consolidation in food retail. These actions generate substantial carryover restructuring benefits which we will quantify when we provide full year guidance in January.
On the right side of the slide are the bolt-on acquisitions we announced in the quarter. Cloeren, which we closed in August, adds extrusion dies and feedblocks to our mag polymer processing platform, along with more than 300,000 square feet of U.S. manufacturing capacity close to the U.S. petrochemical and space launch infrastructure.
Leistung, which we signed and expect to close in the fourth quarter, gives our Clean Energy segment a low-cost state-of-the-art cryogenics components manufacturing presence in India. Both businesses carry excess capacity that other Dover operating companies will leverage its manufacturing hubs in highly strategic locations.
Moving to Slide 10. Our balance sheet remains a competitive advantage and our capital allocation priorities are unchanged. Organic investment generates our highest returns, and we are guiding full year CapEx of $200 million to $220 million, with the capacity and productivity projects I just covered delivering attractive returns into next year. We have committed approximately $80 million to our 2 announced acquisitions. And our pipeline remains active for bolt-on opportunities in high priority markets. We have also repurchased approximately $400 million of shares year-to-date, including $330 million in the third quarter, with over $3 billion of dry powder at quarter end. We have the ample flexibility to play offensive capital allocation and a near-term bias towards returning capital to shareholders.
Let's finish with Slide 11. We are moving our full year guidance towards the upper end of the range. Our focus is on finishing the year strong, and our order book gives us confidence in the forecast with momentum carrying into 2027. Alongside a constructive demand backdrop and a strong order book, we will benefit from carryover restructuring savings contributions from completed acquisitions, a lower share count and a roll-off of transition costs in food retail. We look forward to closing out the year strong and are confident as we enter 2027 from a position of strength.
Over to you, Jack.
Jack Dickens
Leslie, we can go right to the Q&A.
Operator
[Operator Instructions] Our first question comes from Steve Tusa with Wells Fargo.
分析師問答
Charles Stephen Tusa
Just on the backlog, I think it's like a little bit above $3 billion now, I kind of like go back, do the math. And I think you said 50% of that is like shippable for next year. Is there anything in kind of the non-backlog business that you look out to next year that you would be like worried about being unsustainable or dropping off at all?
Richard Tobin
I'd characterize it this way. I guess, where we have been capacity constrained is what's driving the backlog into 2027. So the duration of the demand is a good indicator because customers are basically getting in line to reserve that capacity.
It is not overly influenced from some of our more traditional long-cycle businesses. Maag's pretty much as a bottom, same with Belvac. So it's not -- those numbers aren't influenced by those 2 businesses. So that's actually upside the backlog build as we go into 2027. And then our traditional short-cycle businesses, we don't have a lot of visibility going into next year, and we'll just book and ship as we normally do between now and the end of the year.
Charles Stephen Tusa
Right. And is there any reason for the growth to like slow materially in 4Q? I know you kind of like guided that number. The midpoint is a bit of a slowing. Like anything stand out? I mean the orders have been pretty good, book-to-bill above 1 seasonally.
Richard Tobin
Yes, not really, other than the fact that Q4 is not always in our control, right? We've got the orders, we can make the orders, then it becomes a question at the end of the year whether those orders get called off by our customers or does everybody play a kind of managing the working capital gain at the end of the year. So we're always a little bit cautious because December could go almost either way in any given year. But there's nothing based on the trajectory that we see that's any slowing. It's pure calendarization.
Charles Stephen Tusa
Okay. One more. Just on the buyback you've done, $300 million or something like that. Are you done with that? Or is there still some of that -- you have a ton of cash, ton of capacity is -- can you [ queue ] through some of that?
Richard Tobin
Yes. I think in corporate speak, what we said is that our bias was still on capital return. So take that for what it is.
Charles Stephen Tusa
Great. I don't understand all corporate speak, but that's pretty clear. So I appreciate that.
Operator
Our next question comes from Nigel Coe, Wolfe Research.
Nigel Coe
Maybe, Rich, could you just kind of give us a little kind of sense on the dual cost you called out, I think, $40 million of investment and deal cost that's now behind us. Maybe give us a sense on how you see CST margins in the fourth quarter, but more importantly, going into 2027. And you've said 20% margin target in the past for that segment. Are we on track for that in 2028?
Richard Tobin
Yes. Just for clarity's sake, it's the year-to-date headwind costs of the plant closure and the redundant labor that we've had to run as a result of that. And that's year-to-date, okay? So that number will actually probably go up between now and the end of the year because as line rates come up, we'll absorb that extra labor and then we'll begin to flip it over into productivity. So that's the $40 million.
Yes. I mean I think that we're well on track of meeting the targets that we put on that sector because of 2 things. Number one, that the carryover of not having those costs of consolidation between the 2 years is an add back. The volume across the segment goes up, and so the incremental margin of the fixed cost goes up along with it. So I think that's why I said that we can expect a material change in 2027 in the margin of that particular segment.
Nigel Coe
But no numbers?
Richard Tobin
Come on, Nigel. We're going to give you guidance when we get to the end of the year, but it's material.
Nigel Coe
Okay. You've said 20% of the past. I'm just trying to get a sense on that. But maybe -- can we just talk about the PPS orders -- sorry, not PPS, CST orders? Been strong for a long time now, no sign of slowdown. I'm just wondering maybe if you can just like try and give us another sort of second level detail on SWEP versus CO2 versus core refrigeration.
And I do want to get a sense on one number, Rich, 3% growth in data center this year is impressive. But I would think it'd be even more impressive just given the growth in the market. And I'm wondering if there's any capacity constraints within SWEP that maybe gets released in 2027?
Richard Tobin
Well, yes. I mean I think that if you go on the slide of our capital investments and if you go back and read the transcript of what I said, yes, we've been capacity constrained all year. It doesn't seem to be preventing the actual build-outs, but everybody is trying to get in front of securing the supply. So there's a lot of signaling effect in there. But we are basically ramping to double capacity into the main product line that's been growing. This is SWEP now, that's been sent into data centers. That will change over time because there'll be a shift between the central cooling system demand, which we see it now, into more CDU mix into the future, and we're taking that into consideration.
In terms of the backlog, I don't want to say 50-50, but it's dominated by CO2 systems demand and SWEP.
Operator
Our next question comes from Mike Halloran with Baird.
Michael Halloran
So back to the backlog question on some level, what's the normal conversion ratio at this point? You have your backlog shippable next year. What does that normally look like? And maybe any thoughts on the lead times you're seeing in the industry and if those are starting to extend?
Richard Tobin
It is higher than average that we would see at this time. I said if we go back and read the transcripts, we would expect in a kind of, let's call it, a normal year, for book-to-bill to come down in Q3 just because of the order of magnitude of shipments. But because of the secular growth nature of some of these businesses that we're in, that customers in certain segments are securing supply, so trying to secure capacity, and so that they're ordering well in advance of what we would normally expect. And that's why we gave you the backlog figures, and that's why we tried to monetize how much of that is 2027 because that, in general terms, would not look like that except for the pace of the growth rate in some of those segments.
Michael Halloran
That makes sense. And on the buyback side, M&A side, obviously, it certainly makes sense that you're pushing more on the capital return time short term. But maybe what's just happening on the M&A side of things? Are you getting priced out of deals at this point? Has the activity slowed? Maybe just some thoughts there.
Richard Tobin
Yes. I mean the activity naturally slows in Q4. Very little comes to the market at the end of the year. So whatever has come to market is -- has come to market not to get into certain deals. Look, we've got return criteria that we stick to. So there are some things that we didn't get that we would have liked to get, but the purchase price that those assets sold forward above that criteria at the end of the day.
We'll see in 2027, but we've got a ton on our plate of organic investment, which is probably going to drive as much revenue growth as kind of bolt-on acquisitions would do. So we retain a posture of optionality, meaning that we'll participate in M&A. We've got some interesting stuff in the pipeline. But with all the cash that we're producing that we carried into this year and all the cash that we're going to produce this year, that clearly -- that our stance is now on capital return.
Operator
Our next question is from Joe O'Dea from Vertical Research.
Joseph O'Dea
Could you talk a little bit about pricing and what might be in the pipeline just with respect to the inflationary backdrop? It looked like the price this quarter was pretty similar to the second quarter, maybe a little bit tougher comp. But are you out there in the market and you need to do anything more on the pricing side -- to carryover into next year?
Richard Tobin
Yes, it depends, Joe. I mean we are actually have moved up pricing decisions this year and have been introducing pricing, which in a kind of a stable year of a low inflation environment, we'd kind of wait till the beginning of the year. We've actually accelerated that in certain instances depending on exposure to a variety of different things, whether it's commodity group metals or other things. So I think we're on the front foot of getting ahead of what anybody's view about price cost is going into '27. I think we're actually probably a full quarter in front of getting in front of that.
Joseph O'Dea
And then just another one on the food retail and the production ramp costs. As you think about full year being somewhere above 40, how much of that we can think about as being nonrepeat? Is there a carryover associated with it? Or do you think that those are all kind of contained costs that you'll be able to leverage...
Richard Tobin
It will -- so the speed is coming down as the volumes go up, right, you get the fixed cost absorption benefit. The balance of it is productivity. So it's just winding out kind of extra labor costs as you stabilize the line rates. So we would expect that to progressively get better over the balance of the year and then probably finish up by the end of Q1. But I don't expect the 40 or whatever it ends up being at the end of this year flows through in total going into next year unless volume drops. And based on our backlog right now, we've seen no indication of volume dropping in 2027.
Operator
Our next question comes from Scott Davis with Melius Research.
Steven Winoker
What -- Rich, what happens in retail fueling when prices -- when fuel prices are up this much? Does that create a little bit more cash flow for these guys to invest in their businesses? Seems like that -- it's been a while since we've had a big jump like this. But what does $6 diesel and $4 dollar gas do for these folks?
Richard Tobin
Yes. Not to talk about our customers' profitability, which -- many of which are publicly traded. At the end of the day, earnings spread on fueling products have been up substantially over the past 18 to 24 months, and I don't expect that to narrow. The better news -- so that's great. We like healthy customers that are making a lot of money, number one. And number two, the good part of what we've seen about the CapEx is there is supply constraints in that particular market, and that is just lengthening the duration of what we believe the demand cycle is. So we knew we were coming into a CapEx cycle for a variety of different reasons. We now believe that, that is going to extend. I think we called it out 1.5 years ago, it was a 3-year cycle. It's probably going to -- we could probably argue it's going to be at least 4.
Scott Davis
And is that an area where you're able to get price because of that supply chain dislocation?
Richard Tobin
It's -- in terms of the amount of market participants, it is a market that we like.
Operator
Our next question comes from Andy Kaplowitz, Citigroup.
Andrew Kaplowitz
Rich, so DII margin, I think, was the best margin that segment is recorded. I know you mentioned mix productivity effects, but I think you've been working on structural cost actions in that segment. So when you think about DII's margins even more sustainable, closer to Q3 rates, or maybe was that more of a one-time bump?
Richard Tobin
Look, I look at year-to-date at the end of the day because it's our most global business, there's a lot running through that, that some of our other businesses don't have to deal with specialty FX and then mix because of the disproportionate difference in margin between the consumables and the equipment. So it will move around for that.
Having said that, if you go back and take a look over a 3- to 5-year period, we've steadily marched up the margin in that business through a variety of different measures. We're making some pretty significant investments. We built a brand-new plant in Poland this past year, and we're going to finish up on basically rebuilding our ink production in 2027, so we expect some productivity to come out of that. So yes, I mean, I wouldn't get all excited about the quarters -- this quarter's margin. But if you look at it on a year-to-date basis, that's entirely sustainable.
Andrew Kaplowitz
That's great. And maybe a similar question on Clean Energy & Fueling. If I look at Q3 year-over-year margin, it's a little bit more difficult than the first half. I know you talked about cryo space production ramp impacting margin. But maybe update us some of the platform you created in that business, that journey, I think you talked about the 25% margin. Where is that?
Richard Tobin
Look, we're tracking there, but we've been -- the opportunities that we found on the cryo side over the past 18 months, which is driving the top line, is requiring a lot of investment on our part. So that has got a little bit of a dilutive effect, but we'll take that trade-off any day, right? Because it's driving the top line and they are -- these are businesses with secular growth that once we go through the build phase, we can expect what we saw in SWEP over the last couple of years where we had margins that were down because investment was running forward than the revenue.
Now we've got the revenue in SWEP and so the incremental margin is robust. We'd expect that same kind of trajectory. And that's the reason that we put that slide in about all the organic investments that we're making is, it's not only to kind of explain what we think about the durability of the revenue increase, but it's to give you a signal of we're going to invest here, there's some cost of making those investments. But we believe, over time, the return on invested capital there will be excellent.
Operator
Our next question comes from Brett Linzey, Mizuho.
We will move to our next question. Our next question comes from Amit Mehrotra with UBS.
Amit Mehrotra
Just maybe one quick one. SWEP lead times. Last time I checked in, they were like 25 weeks. Is that still the case? And I think that's where most of your copper exposure is, obviously, copper has come off a little bit, but sort of hit all-time highs in September. I think you have material pass-through on that. So no issue on price cost. Maybe you can enlighten me on that. But maybe there's a margin issue as copper rises in that business? Maybe you can talk about those 2 things?
Richard Tobin
Yes. Let's deal with copper first. I think that it is -- and we do have copper exposure there, but it's built into the pricing mechanism with our supplier contracts in SWEP. I don't know what lead times are off the top of my head. I mean, we're bringing on additional capacity sequentially through the year, but with a pretty big jump this quarter going into Q1, then it becomes a big debate of well, but the lead times keep going out because the orders keep coming in, in advance of that capacity build. Does that wind down in '27? Hard to say. Right now, we don't see it, but we are bringing on more capacity because the fact that we believe in the durability of the demand.
Amit Mehrotra
But it's not measured in years, it's measured in quarters, right?
Richard Tobin
Yes, yes. No, no, we're not -- it's not in years.
Amit Mehrotra
So I guess just my follow-up question, my clarifying question then. If I think about quarterly order in dollar terms over the last 3 quarters. So this year, sort of averaged $2.3 billion to $2.4 billion depending on the quarter. That's about 9%, 10% higher than the average quarterly revenue of this year. I'm sure you're going to tell me to curb my enthusiasm, but is that the wrong way to think about maybe the organic growth opportunity next year?
Richard Tobin
Let me answer it this way. We've given your book-to-bill. Against my own advice, we gave you the number of the backlog increase to get into the high-level math when you don't know what the duration is of the timing of those orders is a fool's game. I'm sure Jack can give you all kinds of clarifying questions, but I can't go there right now.
Amit Mehrotra
I guess that was my question about lead times, right?
Richard Tobin
Yes, yes. Look, I mean we're not losing share because of lead times, right? Because generally speaking, we're in very concentrated markets from a supply base. So those who bring on the capacity proactively tend to win, and that's why we've been investing in advance of some of this demand to the detriment of margins, by the way. But it's -- but they end up being good investments once they roll over and absorb the fixed cost. So we can see that in SWEP right now.
Operator
Our next question is from Andrew Obin, Bank of America.
David Ridley-Lane
This is David Ridley-Lane on for Andrew. Clean Energy & Fueling, there's a comment that you're planning a greenfield expansion and below-ground retail fueling. I know that there is a regulatory or replacement cycle there for underground tanks, but adding capacity expansion suggests that you think this is kind of a multiyear durable cycle. Is that the right interpretation?
Richard Tobin
Yes. I think I answered it a minute ago to Scott. The -- there is capacity constraints and underground equipment to become into compliance on tanks. And that -- and because there's capacity -- by the way, we don't supply. But what that is doing is lengthening the duration of the demand because you can't get the tanks to do the work, right? What we're expanding in is all of the products that are around that where we see robust demand and our margins are quite good. So that's the way I would answer it.
David Ridley-Lane
And just a quick follow-up. Have you been hearing any impact from higher interest rates from any of your more capital planning type businesses? Is that something that's pulled up to your level?
Richard Tobin
None.
David Ridley-Lane
That's very clear.
Operator
Our next question is from Joe Ritchie with Goldman Sachs.
Joseph Ritchie
So Rich, look, the Slide 9 is great, right, gives you a lot of detail on your capacity expansions, organic investments, et cetera. I guess the question I have is as you -- as we're getting closer and closer to 2027, like how much does this set you up for growth beyond '27 based on what you know today? Or do you think there's going to possibly be additional capacity expansion beyond what you've already announced?
Richard Tobin
Well, I hope we have additional capacity expansion, but the capacities that we are laying in are for multiyear, especially the greenfields, right? I mean we're building -- greenfield is like building a new site, and we would never capacitize a new site for the next 12 months unless -- because you never get the return on capital there. So they're all -- have been sized on the initial investment for a multiyear duration. So in a way, if we have the same slide again next year and there are additional capacity on top of it, it's a great sign because it's just more demand than we've sized the initial investment. So right now, these investments we believe that we can capture our share of the market of the growth rates that I think that we showed you on Slide 5.
Joseph Ritchie
Got it. Okay. That's super helpful. And then going back to the question earlier about the $40 million and the $40 million potentially going higher as the year progresses. I guess, quick math, right, taking a look at your revenue year-to-date in CST, it's like -- that equates like roughly 300 basis points, if I'm doing the math right. So I guess the question I have is you get into 2027, like when would you expect to see a turn in CST margins and starting to -- obviously, you've been taking on these extra costs throughout the year and will continue. But I'm just curious when you would expect to be a turn based on what you know today?
Richard Tobin
I think that we will beat our comp in Q1.
Operator
Our next question is from Andrew Buscaglia with BNP Paribas.
Andrew Buscaglia
If you could -- just kind of tying this all together, I get -- sort of get the sense -- your outlook for '27 or your confidence in '27 has improved in the last few months. I mean just based on some of these higher-growth markets and like the visibility you have. Am I right in that, that's the core reason you're kind of sounding better on '27 or sounding positive on '27 or -- or Slide 6 sort of suggests like your underlying just kind of core markets are seeing some improvements cyclically. So I guess where is more of the confidence coming from? Is that high-growth stuff or like that core business?
Richard Tobin
Yes. Well, I mean, the slides are put in there for a reason, and it's the trajectory growth rates on where we've been investing, have -- I mean, we're looking at, I don't know, what did we say, 500 basis points of improvement over the past 24 or not even 24 months, 20 months. So that we're good there. And we have a data point in terms of orders and backlog earlier this year than we would have in a normal year. So growth -- where we've chosen to participate, those markets are performing well. And the customers that we have across the broader portfolio are beginning to order into 2027 for a variety of reasons that we usually are kind of cautious until we get into giving full year guidance because usually, we don't have that kind of visibility.
Andrew Buscaglia
Yes. That's the sense I get. Okay. And then just on the heat exchanger side, you talked about -- you sort of said you hope you have more capacity investments because I mean things are probably going well. What are capacity requirements like heat exchangers, in your opinion? And then just given the really strong growth we're seeing in that data center cooling side, what's the competitive dynamics there? That's always been sort of a risk that you're not alone in identifying this growth in -- yes, if you could kind of comment on that too, please?
Richard Tobin
Yes. Everybody wants to be in data centers. I see the M&A presentations all the time. Look, this is -- that's a highly automated process. You need to make capacity decisions 18 months in advance before them coming online. So this is not kind of hire a bunch of people and get bigger throughput. It's actually very little people in the process. And so it's a very highly engineered -- probably one of the most highly engineered products that we have in the entire portfolio.
It's a very concentrated market, but those competitors that we have, if you went and looked, are also announcing capacity expansion. So I don't -- I think that we've done a very good job of proactively investing in capacity in advance of the market to the detriment of margins in the past. So we'll get our fair share here.
But I can't disagree with you. I mean everybody wants to be in data center. So you've got to be -- we're going to find out altogether about the duration of the demand. Right now, I don't think we're getting over our skis just because our backlog says what it is, and we believe there is going to be a conversion into more CDU mix than we see now. But I think that we're positioned competitively and from a capacity point of view, appropriately.
Operator
Our final question comes from Brandon Knutson, Morgan Stanley.
Brandon Knutson
Just a quick follow-up on CST mark. So you said it's going to be stronger -- growth from -- flat. A lot of that...
Jack Dickens
Brandon, we're having a hard time hearing you. Are you far away from the microphone?
Brandon Knutson
Hello?
Jack Dickens
Hey, can you hear us, Brandon?
Brandon Knutson
Yes. Can you hear me?
Jack Dickens
Yes, we can hear you now. Go ahead.
Brandon Knutson
CST, you saw strong growth accelerate the margins...
Richard Tobin
Brandon, you're cutting out. You know what, give Jack a call, he'll get to you. But -- you're cutting in and out.
Jack Dickens
Okay. I think we can wrap up the call, Leslie.
Operator
That concludes our question-and-answer period and Dover's Third Quarter 2026 Earnings Conference Call. You may now disconnect your line at this time, and have a wonderful day.
本文部分內容由 AI 生成和翻譯,並經人工審核,僅供參考且做為一般資訊用途,不構成投資建議。








